07/03/2023 |
NUCYNTA NDA #022304 |
SUPPL-24 |
TAPENTADOL HYDROCHLORIDE |
COLLEGIUM PHARM INC |
Efficacy |
Approval |
07/03/2023 |
BENZTROPINE MESYLATE ANDA #090233 |
SUPPL-4 |
BENZTROPINE MESYLATE |
FRESENIUS KABI USA |
Labeling |
Approval |
07/03/2023 |
NUCYNTA NDA #203794 |
SUPPL-10 |
TAPENTADOL HYDROCHLORIDE |
COLLEGIUM PHARM INC |
Efficacy |
Approval |
07/03/2023 |
DEXMEDETOMIDINE HYDROCHLORIDE ANDA #205867 |
SUPPL-11 |
DEXMEDETOMIDINE HYDROCHLORIDE |
EUGIA PHARMA |
Labeling |
Approval |
07/03/2023 |
OSELTAMIVIR PHOSPHATE ANDA #209113 |
SUPPL-10 |
OSELTAMIVIR PHOSPHATE |
ZYDUS PHARMS |
Labeling |
Approval |
07/03/2023 |
OSELTAMIVIR PHOSPHATE ANDA #209113 |
SUPPL-12 |
OSELTAMIVIR PHOSPHATE |
ZYDUS PHARMS |
Labeling |
Approval |
07/03/2023 |
SUBLOCADE NDA #209819 |
SUPPL-24 |
BUPRENORPHINE |
INDIVIOR |
REMS |
Approval |
07/03/2023 |
DEXMEDETOMIDINE HYDROCHLORIDE ANDA #210321 |
SUPPL-6 |
DEXMEDETOMIDINE HYDROCHLORIDE |
EUGIA PHARMA |
Labeling |
Approval |
07/03/2023 |
METOPROLOL SUCCINATE ANDA #211143 |
SUPPL-4 |
METOPROLOL SUCCINATE |
ALKEM LABS LTD |
Labeling |
Approval |
07/03/2023 |
OXCARBAZEPINE ANDA #211747 |
ORIG-1 |
OXCARBAZEPINE |
ZYDUS |
|
Approval |
07/03/2023 |
KETOROLAC TROMETHAMINE ANDA #212939 |
SUPPL-1 |
KETOROLAC TROMETHAMINE |
EUGIA PHARMA |
Labeling |
Approval |
07/03/2023 |
KETOROLAC TROMETHAMINE ANDA #212939 |
SUPPL-2 |
KETOROLAC TROMETHAMINE |
EUGIA PHARMA |
Labeling |
Approval |
07/03/2023 |
DOLUTEGRAVIR ANDA #216470 |
ORIG-1 |
DOLUTEGRAVIR |
LUPIN LTD |
|
Tentative Approval |
07/03/2023 |
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE ANDA #217511 |
ORIG-1 |
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE |
RICONPHARMA LLC |
|
Approval |
07/05/2023 |
LOPRESSOR NDA #017963 |
SUPPL-74 |
METOPROLOL TARTRATE |
VALIDUS PHARMS |
Labeling |
Approval |
07/05/2023 |
VICTOZA NDA #022341 |
SUPPL-39 |
LIRAGLUTIDE |
NOVO NORDISK INC |
Labeling |
Approval |
07/05/2023 |
INVOKANA NDA #204042 |
SUPPL-40 |
CANAGLIFLOZIN |
JANSSEN PHARMS |
Labeling |
Approval |
07/05/2023 |
INVOKAMET NDA #204353 |
SUPPL-42 |
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
JANSSEN PHARMS |
Labeling |
Approval |
07/05/2023 |
INVOKAMET XR NDA #205879 |
SUPPL-19 |
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
JANSSEN PHARMS |
Labeling |
Approval |
07/05/2023 |
DOCETAXEL NDA #205934 |
SUPPL-6 |
DOCETAXEL |
SHILPA |
Labeling |
Approval |
07/05/2023 |
GLATOPA ANDA #206921 |
SUPPL-28 |
GLATIRAMER ACETATE |
SANDOZ |
Labeling |
Approval |
07/05/2023 |
CABAZITAXEL ANDA #207381 |
ORIG-1 |
CABAZITAXEL |
MYLAN LABS LTD |
|
Approval |
07/05/2023 |
FAMOTIDINE ANDA #215630 |
SUPPL-3 |
FAMOTIDINE |
ALKEM LABS LTD |
Manufacturing (CMC) |
Approval |
07/05/2023 |
LOPERAMIDE HYDROCHLORIDE ANDA #217840 |
ORIG-1 |
LOPERAMIDE HYDROCHLORIDE |
JUBILANT CADISTA |
|
Approval |
07/06/2023 |
PROMACTA NDA #022291 |
SUPPL-38 |
ELTROMBOPAG OLAMINE |
NOVARTIS |
Manufacturing (CMC) |
Approval |
07/06/2023 |
NALTREXONE ANDA #213195 |
ORIG-1 |
NALTREXONE |
TEVA PHARMS USA INC |
|
Approval |
07/06/2023 |
ADAPALENE ANDA #215940 |
SUPPL-1 |
ADAPALENE |
TARO |
Manufacturing (CMC) |
Approval |
07/06/2023 |
FOMEPIZOLE ANDA #216791 |
ORIG-1 |
FOMEPIZOLE |
GLAND PHARMA LTD |
|
Approval |
07/06/2023 |
LEQEMBI BLA #761269 |
SUPPL-1 |
LECANEMAB-IRMB |
EISAI INC |
|
Approval |
07/07/2023 |
JEVTANA KIT NDA #201023 |
SUPPL-26 |
CABAZITAXEL |
SANOFI AVENTIS US |
Labeling |
Approval |
07/07/2023 |
TAPENTADOL ANDA #205016 |
ORIG-1 |
TAPENTADOL |
ALKEM LABS LTD |
|
Tentative Approval |
07/07/2023 |
VILAZODONE HYDROCHLORIDE ANDA #208228 |
ORIG-1 |
VILAZODONE HYDROCHLORIDE |
APOTEX |
|
Approval |
07/07/2023 |
LEQVIO NDA #214012 |
SUPPL-9 |
INCLISIRAN SODIUM |
NOVARTIS |
Labeling |
Approval |
07/07/2023 |
DEXAMETHASONE SODIUM PHOSPHATE ANDA #214890 |
ORIG-1 |
DEXAMETHASONE SODIUM PHOSPHATE |
GENEYORK PHARMS |
|
Approval |
07/07/2023 |
NICARDIPINE HYDROCHLORIDE ANDA #216420 |
ORIG-1 |
NICARDIPINE HYDROCHLORIDE |
MICRO LABS |
|
Approval |
07/07/2023 |
FAMOTIDINE ANDA #217137 |
ORIG-1 |
FAMOTIDINE |
CARNEGIE |
|
Approval |
07/10/2023 |
CLARITHROMYCIN ANDA #065155 |
SUPPL-13 |
CLARITHROMYCIN |
TEVA |
Labeling |
Approval |
07/10/2023 |
CLARITHROMYCIN ANDA #065155 |
SUPPL-14 |
CLARITHROMYCIN |
TEVA |
Labeling |
Approval |
07/10/2023 |
CLARITHROMYCIN ANDA #065155 |
SUPPL-15 |
CLARITHROMYCIN |
TEVA |
Labeling |
Approval |
07/10/2023 |
CLARITHROMYCIN ANDA #065155 |
SUPPL-17 |
CLARITHROMYCIN |
TEVA |
Labeling |
Approval |
07/10/2023 |
CLARITHROMYCIN ANDA #065155 |
SUPPL-20 |
CLARITHROMYCIN |
TEVA |
Labeling |
Approval |
07/10/2023 |
CAPECITABINE ANDA #091649 |
SUPPL-15 |
CAPECITABINE |
TEVA PHARMS USA |
Labeling |
Approval |
07/10/2023 |
KETOROLAC TROMETHAMINE ANDA #201155 |
SUPPL-3 |
KETOROLAC TROMETHAMINE |
STERISCIENCE |
Labeling |
Approval |
07/10/2023 |
KETOROLAC TROMETHAMINE ANDA #201155 |
SUPPL-4 |
KETOROLAC TROMETHAMINE |
STERISCIENCE |
Labeling |
Approval |
07/10/2023 |
KETOROLAC TROMETHAMINE ANDA #204216 |
SUPPL-11 |
KETOROLAC TROMETHAMINE |
GLAND |
Labeling |
Approval |
07/10/2023 |
KETOROLAC TROMETHAMINE ANDA #204216 |
SUPPL-13 |
KETOROLAC TROMETHAMINE |
GLAND |
Labeling |
Approval |
07/10/2023 |
TOBRAMYCIN ANDA #205501 |
SUPPL-13 |
TOBRAMYCIN |
AMNEAL PHARMS |
Labeling |
Approval |
07/10/2023 |
TOBRAMYCIN ANDA #207080 |
SUPPL-12 |
TOBRAMYCIN |
DR REDDYS LABS SA |
Labeling |
Approval |
07/10/2023 |
XULTOPHY 100/3.6 BLA #208583 |
SUPPL-21 |
INSULIN DEGLUDEC; LIRAGLUTIDE |
NOVO |
|
Approval |
07/10/2023 |
DIVALPROEX SODIUM ANDA #209286 |
SUPPL-8 |
DIVALPROEX SODIUM |
LUPIN LTD |
Labeling |
Approval |
07/10/2023 |
CLONIDINE HYDROCHLORIDE ANDA #209757 |
SUPPL-2 |
CLONIDINE HYDROCHLORIDE |
XIAMEN LP PHARM CO |
Labeling |
Approval |
07/10/2023 |
ATORVASTATIN CALCIUM ANDA #209912 |
SUPPL-23 |
ATORVASTATIN CALCIUM |
GRAVITI PHARMS |
Labeling |
Approval |
07/10/2023 |
BUPROPION HYDROCHLORIDE ANDA #211347 |
SUPPL-10 |
BUPROPION HYDROCHLORIDE |
YICHANG HUMANWELL |
Labeling |
Approval |
07/10/2023 |
ATORVASTATIN CALCIUM ANDA #211933 |
SUPPL-17 |
ATORVASTATIN CALCIUM |
MSN |
Labeling |
Approval |
07/10/2023 |
RAMELTEON ANDA #215972 |
ORIG-1 |
RAMELTEON |
AUROBINDO PHARMA LTD |
|
Approval |
07/10/2023 |
ACETAMINOPHEN AND IBUPROFEN ANDA #216994 |
ORIG-1 |
ACETAMINOPHEN; IBUPROFEN |
MARKSANS PHARMA |
|
Approval |
07/10/2023 |
LEUCOVORIN CALCIUM ANDA #217021 |
ORIG-1 |
LEUCOVORIN CALCIUM |
HAINAN POLY |
|
Approval |
07/11/2023 |
ALEVE-D SINUS & COLD NDA #021076 |
SUPPL-19 |
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE |
BAYER |
Labeling |
Approval |
07/11/2023 |
ATORVASTATIN CALCIUM ANDA #091226 |
SUPPL-30 |
ATORVASTATIN CALCIUM |
MYLAN PHARMS INC |
Labeling |
Approval |
07/11/2023 |
DIVALPROEX SODIUM ANDA #202419 |
SUPPL-27 |
DIVALPROEX SODIUM |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
07/11/2023 |
OLMESARTAN MEDOXOMIL ANDA #207480 |
ORIG-1 |
OLMESARTAN MEDOXOMIL |
AMNEAL |
|
Approval |
07/11/2023 |
SEVELAMER HYDROCHLORIDE ANDA #212599 |
ORIG-1 |
SEVELAMER HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
|
Approval |
07/11/2023 |
BROMFENAC ANDA #212964 |
ORIG-1 |
BROMFENAC |
EUGIA PHARMA SPECLTS |
|
Tentative Approval |
07/11/2023 |
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) ANDA #217357 |
ORIG-1 |
NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE |
MANKIND PHARMA |
|
Approval |
07/11/2023 |
STERILE WATER FOR INJECTION ANDA #217536 |
ORIG-1 |
STERILE WATER FOR INJECTION |
NEXUS |
|
Approval |
07/11/2023 |
LIDOCAINE HYDROCHLORIDE ANDA #217693 |
ORIG-1 |
LIDOCAINE HYDROCHLORIDE |
MANKIND PHARMA |
|
Approval |
07/11/2023 |
SODIUM CHLORIDE 23.4% ANDA #217796 |
ORIG-1 |
SODIUM CHLORIDE |
FRESENIUS KABI USA |
|
Approval |
07/11/2023 |
HADLIMA BLA #761059 |
SUPPL-8 |
ADALIMUMAB-BWWD |
SAMSUNG BIOEPIS CO LTD |
|
Approval |
07/12/2023 |
JEANATOPE BLA #017836 |
SUPPL-9 |
ALBUMIN IODINATED I-125 SERUM |
ISO TEX |
|
Approval |
07/12/2023 |
DIFLUCAN NDA #019949 |
SUPPL-74 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
07/12/2023 |
DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER NDA #019950 |
SUPPL-73 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
07/12/2023 |
DIFLUCAN IN SODIUM CHLORIDE 0.9% NDA #019950 |
SUPPL-73 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
07/12/2023 |
DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER NDA #019950 |
SUPPL-73 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
07/12/2023 |
HEPARIN SODIUM 20,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER NDA #019952 |
SUPPL-48 |
HEPARIN SODIUM |
B BRAUN |
Labeling |
Approval |
07/12/2023 |
HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER NDA #019952 |
SUPPL-48 |
HEPARIN SODIUM |
B BRAUN |
Labeling |
Approval |
07/12/2023 |
DIFLUCAN NDA #020090 |
SUPPL-55 |
FLUCONAZOLE |
PFIZER |
Labeling |
Approval |
07/12/2023 |
XIAFLEX BLA #125338 |
SUPPL-111 |
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM |
AUXILIUM PHARMS |
|
Approval |
07/12/2023 |
TELMISARTAN AND HYDROCHLOROTHIAZIDE ANDA #202544 |
SUPPL-7 |
HYDROCHLOROTHIAZIDE; TELMISARTAN |
GLENMARK PHARMS LTD |
Labeling |
Approval |
07/12/2023 |
VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #206083 |
SUPPL-5 |
HYDROCHLOROTHIAZIDE; VALSARTAN |
PRINSTON INC |
Labeling |
Approval |
07/12/2023 |
VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #206083 |
SUPPL-6 |
HYDROCHLOROTHIAZIDE; VALSARTAN |
PRINSTON INC |
Labeling |
Approval |
07/12/2023 |
VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #206083 |
SUPPL-7 |
HYDROCHLOROTHIAZIDE; VALSARTAN |
PRINSTON INC |
Labeling |
Approval |
07/12/2023 |
PREGABALIN ANDA #206452 |
ORIG-1 |
PREGABALIN |
CADILA PHARMS LTD |
|
Approval |
07/12/2023 |
DOXYCYCLINE HYCLATE ANDA #208818 |
SUPPL-5 |
DOXYCYCLINE HYCLATE |
LUPIN LTD |
Labeling |
Approval |
07/12/2023 |
DOXYCYCLINE HYCLATE ANDA #208818 |
SUPPL-6 |
DOXYCYCLINE HYCLATE |
LUPIN LTD |
Labeling |
Approval |
07/12/2023 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #208861 |
SUPPL-1 |
METHYLPHENIDATE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
07/12/2023 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #208861 |
SUPPL-7 |
METHYLPHENIDATE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
07/12/2023 |
NALOXONE HYDROCHLORIDE ANDA #208871 |
SUPPL-1 |
NALOXONE HYDROCHLORIDE |
RISING |
Labeling |
Approval |
07/12/2023 |
NALOXONE HYDROCHLORIDE ANDA #208871 |
SUPPL-4 |
NALOXONE HYDROCHLORIDE |
RISING |
Labeling |
Approval |
07/12/2023 |
NALOXONE HYDROCHLORIDE ANDA #208872 |
SUPPL-3 |
NALOXONE HYDROCHLORIDE |
RISING |
Labeling |
Approval |
07/12/2023 |
DOXORUBICIN HYDROCHLORIDE ANDA #208888 |
SUPPL-2 |
DOXORUBICIN HYDROCHLORIDE |
AMNEAL |
Labeling |
Approval |
07/12/2023 |
DOXORUBICIN HYDROCHLORIDE ANDA #208888 |
SUPPL-3 |
DOXORUBICIN HYDROCHLORIDE |
AMNEAL |
Labeling |
Approval |
07/12/2023 |
LACOSAMIDE ANDA #209301 |
SUPPL-1 |
LACOSAMIDE |
HETERO LABS LTD III |
Labeling |
Approval |
07/12/2023 |
LEVOLEUCOVORIN CALCIUM ANDA #210892 |
SUPPL-1 |
LEVOLEUCOVORIN CALCIUM |
GLAND PHARMA LTD |
Labeling |
Approval |
07/12/2023 |
LEVOLEUCOVORIN CALCIUM ANDA #210892 |
SUPPL-3 |
LEVOLEUCOVORIN CALCIUM |
GLAND PHARMA LTD |
Labeling |
Approval |
07/12/2023 |
HYDROXYCHLOROQUINE SULFATE ANDA #210959 |
SUPPL-10 |
HYDROXYCHLOROQUINE SULFATE |
LAURUS |
Labeling |
Approval |
07/12/2023 |
HYDROXYCHLOROQUINE SULFATE ANDA #210959 |
SUPPL-12 |
HYDROXYCHLOROQUINE SULFATE |
LAURUS |
Labeling |
Approval |
07/12/2023 |
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE NDA #211868 |
ORIG-1 |
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
EMCURE PHARMS LTD |
Type 4 - New Combination |
Tentative Approval |
07/12/2023 |
POTASSIUM CHLORIDE ANDA #212816 |
ORIG-1 |
POTASSIUM CHLORIDE |
NOVITIUM PHARMA |
|
Approval |
07/12/2023 |
ESOMEPRAZOLE MAGNESIUM ANDA #214473 |
ORIG-1 |
ESOMEPRAZOLE MAGNESIUM |
AUROBINDO PHARMA LTD |
|
Approval |
07/12/2023 |
PEMETREXED DISODIUM ANDA #214632 |
SUPPL-1 |
PEMETREXED DISODIUM |
EUGIA PHARMA |
Labeling |
Approval |
07/12/2023 |
DOCETAXEL ANDA #215744 |
SUPPL-2 |
DOCETAXEL |
ALEMBIC |
Labeling |
Approval |
07/12/2023 |
GUAIFENESIN ANDA #215932 |
SUPPL-3 |
GUAIFENESIN |
DR REDDYS |
Labeling |
Approval |
07/12/2023 |
METRONIDAZOLE ANDA #216323 |
ORIG-1 |
METRONIDAZOLE |
COSETTE |
|
Approval |
07/12/2023 |
MAGNESIUM SULFATE IN PLASTIC CONTAINER ANDA #216597 |
SUPPL-1 |
MAGNESIUM SULFATE |
AMNEAL |
Labeling |
Approval |
07/12/2023 |
AMJEVITA BLA #761024 |
SUPPL-17 |
ADALIMUMAB-ATTO |
AMGEN INC |
|
Approval |
07/13/2023 |
OPILL NDA #017031 |
SUPPL-41 |
NORGESTREL |
LABORATOIRE HRA |
Efficacy |
Approval |
07/13/2023 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM ANDA #070627 |
SUPPL-9 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HIKMA |
Labeling |
Approval |
07/13/2023 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM ANDA #070627 |
SUPPL-10 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HIKMA |
Labeling |
Approval |
07/13/2023 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM ANDA #070628 |
SUPPL-12 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HIKMA |
Labeling |
Approval |
07/13/2023 |
SULFAMETHOXAZOLE AND TRIMETHOPRIM ANDA #070628 |
SUPPL-13 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
HIKMA |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079169 |
SUPPL-9 |
ROSUVASTATIN CALCIUM |
SUN PHARM |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079169 |
SUPPL-12 |
ROSUVASTATIN CALCIUM |
SUN PHARM |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079169 |
SUPPL-13 |
ROSUVASTATIN CALCIUM |
SUN PHARM |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079169 |
SUPPL-15 |
ROSUVASTATIN CALCIUM |
SUN PHARM |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079171 |
SUPPL-6 |
ROSUVASTATIN CALCIUM |
SANDOZ |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079171 |
SUPPL-7 |
ROSUVASTATIN CALCIUM |
SANDOZ |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079171 |
SUPPL-13 |
ROSUVASTATIN CALCIUM |
SANDOZ |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079172 |
SUPPL-7 |
ROSUVASTATIN CALCIUM |
GLENMARK PHARMS |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079172 |
SUPPL-10 |
ROSUVASTATIN CALCIUM |
GLENMARK PHARMS |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079172 |
SUPPL-14 |
ROSUVASTATIN CALCIUM |
GLENMARK PHARMS |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #079172 |
SUPPL-15 |
ROSUVASTATIN CALCIUM |
GLENMARK PHARMS |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #201619 |
SUPPL-4 |
ROSUVASTATIN CALCIUM |
TORRENT |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #201619 |
SUPPL-5 |
ROSUVASTATIN CALCIUM |
TORRENT |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #201619 |
SUPPL-9 |
ROSUVASTATIN CALCIUM |
TORRENT |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #201619 |
SUPPL-10 |
ROSUVASTATIN CALCIUM |
TORRENT |
Labeling |
Approval |
07/13/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #202353 |
SUPPL-6 |
PRAMIPEXOLE DIHYDROCHLORIDE |
SANDOZ |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #205587 |
SUPPL-3 |
ROSUVASTATIN CALCIUM |
LUPIN |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #206381 |
SUPPL-2 |
ROSUVASTATIN CALCIUM |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #206381 |
SUPPL-3 |
ROSUVASTATIN CALCIUM |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/13/2023 |
ROSUVASTATIN CALCIUM ANDA #206381 |
SUPPL-6 |
ROSUVASTATIN CALCIUM |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/13/2023 |
ENZALUTAMIDE ANDA #211465 |
ORIG-1 |
ENZALUTAMIDE |
EUGIA PHARMA |
|
Tentative Approval |
07/13/2023 |
CHLORPROMAZINE HYDROCHLORIDE ANDA #213327 |
ORIG-1 |
CHLORPROMAZINE HYDROCHLORIDE |
LUPIN |
|
Approval |
07/13/2023 |
OXCARBAZEPINE ANDA #213369 |
ORIG-1 |
OXCARBAZEPINE |
APOTEX |
|
Approval |
07/13/2023 |
VEKLURY NDA #214787 |
SUPPL-19 |
REMDESIVIR |
GILEAD SCIENCES INC |
Efficacy |
Approval |
07/13/2023 |
ACETAMINOPHEN AND IBUPROFEN ANDA #216592 |
ORIG-1 |
ACETAMINOPHEN; IBUPROFEN |
GRANULES |
|
Approval |
07/13/2023 |
ERTUGLIFLOZIN ANDA #216947 |
ORIG-1 |
ERTUGLIFLOZIN |
AUROBINDO PHARMA LTD |
|
Approval |
07/14/2023 |
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ANDA #076766 |
SUPPL-14 |
FLUCONAZOLE |
BAXTER HLTHCARE |
Labeling |
Approval |
07/14/2023 |
TELMISARTAN ANDA #202397 |
SUPPL-10 |
TELMISARTAN |
MYLAN |
Labeling |
Approval |
07/14/2023 |
TELMISARTAN ANDA #202397 |
SUPPL-11 |
TELMISARTAN |
MYLAN |
Labeling |
Approval |
07/14/2023 |
ROSUVASTATIN CALCIUM ANDA #206465 |
SUPPL-8 |
ROSUVASTATIN CALCIUM |
ALKEM LABS LTD |
Labeling |
Approval |
07/14/2023 |
ROSUVASTATIN CALCIUM ANDA #206465 |
SUPPL-9 |
ROSUVASTATIN CALCIUM |
ALKEM LABS LTD |
Labeling |
Approval |
07/14/2023 |
ROSUVASTATIN CALCIUM ANDA #206465 |
SUPPL-14 |
ROSUVASTATIN CALCIUM |
ALKEM LABS LTD |
Labeling |
Approval |
07/14/2023 |
ROSUVASTATIN CALCIUM ANDA #206465 |
SUPPL-15 |
ROSUVASTATIN CALCIUM |
ALKEM LABS LTD |
Labeling |
Approval |
07/14/2023 |
AUROVELA 24 FE ANDA #207504 |
SUPPL-9 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
AUROBINDO PHARMA |
Labeling |
Approval |
07/14/2023 |
AUROVELA 24 FE ANDA #207504 |
SUPPL-12 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
AUROBINDO PHARMA |
Labeling |
Approval |
07/14/2023 |
HAILEY FE 1.5/30 ANDA #209031 |
SUPPL-5 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
GLENMARK PHARMS |
Labeling |
Approval |
07/14/2023 |
HAILEY FE 1.5/30 ANDA #209031 |
SUPPL-6 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
GLENMARK PHARMS |
Labeling |
Approval |
07/14/2023 |
KETOROLAC TROMETHAMINE ANDA #209900 |
SUPPL-4 |
KETOROLAC TROMETHAMINE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
07/14/2023 |
KETOROLAC TROMETHAMINE ANDA #209900 |
SUPPL-6 |
KETOROLAC TROMETHAMINE |
BAXTER HLTHCARE CORP |
Labeling |
Approval |
07/14/2023 |
APREMILAST ANDA #211756 |
ORIG-1 |
APREMILAST |
DR REDDYS |
|
Approval |
07/14/2023 |
KETOROLAC TROMETHAMINE ANDA #214456 |
SUPPL-1 |
KETOROLAC TROMETHAMINE |
ALEMBIC |
Labeling |
Approval |
07/14/2023 |
KETOROLAC TROMETHAMINE ANDA #214456 |
SUPPL-3 |
KETOROLAC TROMETHAMINE |
ALEMBIC |
Labeling |
Approval |
07/14/2023 |
PONATINIB HYDROCHLORIDE ANDA #215893 |
ORIG-1 |
PONATINIB HYDROCHLORIDE |
APOTEX |
|
Approval |
07/14/2023 |
ACALABRUTINIB ANDA #216405 |
ORIG-1 |
ACALABRUTINIB |
SANDOZ INC |
|
Tentative Approval |
07/14/2023 |
BISOPROLOL FUMARATE ANDA #217368 |
ORIG-1 |
BISOPROLOL FUMARATE |
PRINSTON INC |
|
Approval |
07/14/2023 |
SODIUM PHENYLACETATE AND SODIUM BENZOATE ANDA #217526 |
ORIG-1 |
SODIUM BENZOATE; SODIUM PHENYLACETATE |
NAVINTA LLC |
|
Approval |
07/14/2023 |
DUPIXENT BLA #761055 |
SUPPL-50 |
DUPILUMAB |
REGENERON PHARMACEUTICALS |
|
Approval |
07/17/2023 |
SODIUM PHOSPHATES IN PLASTIC CONTAINER NDA #018892 |
SUPPL-37 |
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS |
HOSPIRA |
Manufacturing (CMC) |
Approval |
07/17/2023 |
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ANDA #076303 |
SUPPL-25 |
FLUCONAZOLE |
HOSPIRA |
Labeling |
Approval |
07/17/2023 |
FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER ANDA #076303 |
SUPPL-26 |
FLUCONAZOLE |
HOSPIRA |
Labeling |
Approval |
07/17/2023 |
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER ANDA #076304 |
SUPPL-24 |
FLUCONAZOLE |
HOSPIRA |
Labeling |
Approval |
07/17/2023 |
FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER ANDA #076304 |
SUPPL-25 |
FLUCONAZOLE |
HOSPIRA |
Labeling |
Approval |
07/17/2023 |
MEPERIDINE HYDROCHLORIDE ANDA #088640 |
SUPPL-41 |
MEPERIDINE HYDROCHLORIDE |
BARR |
Labeling |
Approval |
07/17/2023 |
MEPERIDINE HYDROCHLORIDE ANDA #088640 |
SUPPL-43 |
MEPERIDINE HYDROCHLORIDE |
BARR |
Labeling |
Approval |
07/17/2023 |
MEPERIDINE HYDROCHLORIDE ANDA #088640 |
SUPPL-47 |
MEPERIDINE HYDROCHLORIDE |
BARR |
Labeling |
Approval |
07/17/2023 |
LARIN FE 1.5/30 ANDA #091453 |
SUPPL-8 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
NOVAST LABS |
Labeling |
Approval |
07/17/2023 |
LARIN FE 1.5/30 ANDA #091453 |
SUPPL-9 |
ETHINYL ESTRADIOL; NORETHINDRONE ACETATE |
NOVAST LABS |
Labeling |
Approval |
07/17/2023 |
VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #091519 |
SUPPL-4 |
HYDROCHLOROTHIAZIDE; VALSARTAN |
WATSON LABS TEVA |
Labeling |
Approval |
07/17/2023 |
VALSARTAN AND HYDROCHLOROTHIAZIDE ANDA #091519 |
SUPPL-5 |
HYDROCHLOROTHIAZIDE; VALSARTAN |
WATSON LABS TEVA |
Labeling |
Approval |
07/17/2023 |
ARIPIPRAZOLE ANDA #207105 |
SUPPL-2 |
ARIPIPRAZOLE |
ALKEM LABS LTD |
Labeling |
Approval |
07/17/2023 |
ARIPIPRAZOLE ANDA #207105 |
SUPPL-3 |
ARIPIPRAZOLE |
ALKEM LABS LTD |
Labeling |
Approval |
07/17/2023 |
ARIPIPRAZOLE ANDA #207105 |
SUPPL-8 |
ARIPIPRAZOLE |
ALKEM LABS LTD |
Labeling |
Approval |
07/17/2023 |
BETAMETHASONE DIPROPIONATE ANDA #214048 |
SUPPL-5 |
BETAMETHASONE DIPROPIONATE |
ZYDUS LIFESCIENCES |
Labeling |
Approval |
07/17/2023 |
CYCLOPHOSPHAMIDE ANDA #214529 |
ORIG-1 |
CYCLOPHOSPHAMIDE |
SAGENT PHARMS INC |
|
Approval |
07/17/2023 |
HYDROCORTISONE ANDA #214649 |
ORIG-1 |
HYDROCORTISONE |
AUROBINDO PHARMA LTD |
|
Approval |
07/17/2023 |
NICARDIPINE HYDROCHLORIDE ANDA #215377 |
ORIG-1 |
NICARDIPINE HYDROCHLORIDE |
SENORES PHARMS |
|
Approval |
07/17/2023 |
TOPIRAMATE ANDA #215414 |
SUPPL-1 |
TOPIRAMATE |
ASCENT PHARMS INC |
Labeling |
Approval |
07/17/2023 |
TOPIRAMATE ANDA #215414 |
SUPPL-2 |
TOPIRAMATE |
ASCENT PHARMS INC |
Labeling |
Approval |
07/17/2023 |
ENCORAFENIB ANDA #217404 |
ORIG-1 |
ENCORAFENIB |
SANDOZ INC |
|
Tentative Approval |
07/17/2023 |
GABAPENTIN ANDA #217546 |
SUPPL-1 |
GABAPENTIN |
LAURUS |
Labeling |
Approval |
07/17/2023 |
TEPEZZA BLA #761143 |
SUPPL-23 |
TEPROTUMUMAB-TRBW |
HORIZON THERAPEUTICS IRELAND |
|
Approval |
07/17/2023 |
BEYFORTUS BLA #761328 |
ORIG-1 |
NIRSEVIMAB-ALIP |
ASTRAZENECA AB |
|
Approval |
07/18/2023 |
ACIPHEX NDA #020973 |
SUPPL-43 |
RABEPRAZOLE SODIUM |
WAYLIS THERAP |
Labeling |
Approval |
07/18/2023 |
PROTONIX NDA #020987 |
SUPPL-60 |
PANTOPRAZOLE SODIUM |
WYETH PHARMS |
Labeling |
Approval |
07/18/2023 |
PROTONIX IV NDA #020988 |
SUPPL-69 |
PANTOPRAZOLE SODIUM |
WYETH PHARMS |
Labeling |
Approval |
07/18/2023 |
ZYVOX NDA #021130 |
SUPPL-44 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
07/18/2023 |
ZYVOX NDA #021131 |
SUPPL-41 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
07/18/2023 |
ZYVOX NDA #021132 |
SUPPL-43 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
07/18/2023 |
NEXIUM NDA #021153 |
SUPPL-60 |
ESOMEPRAZOLE MAGNESIUM |
ASTRAZENECA |
Labeling |
Approval |
07/18/2023 |
ZEGERID NDA #021636 |
SUPPL-25 |
OMEPRAZOLE; SODIUM BICARBONATE |
SALIX |
Labeling |
Approval |
07/18/2023 |
NEXIUM IV NDA #021689 |
SUPPL-38 |
ESOMEPRAZOLE SODIUM |
ASTRAZENECA |
Labeling |
Approval |
07/18/2023 |
ZEGERID NDA #021849 |
SUPPL-20 |
OMEPRAZOLE; SODIUM BICARBONATE |
SALIX |
Labeling |
Approval |
07/18/2023 |
ABSORICA NDA #021951 |
SUPPL-23 |
ISOTRETINOIN |
SUN PHARM INDS INC |
Labeling |
Approval |
07/18/2023 |
ABSORICA NDA #021951 |
SUPPL-24 |
ISOTRETINOIN |
SUN PHARM INDS INC |
Labeling |
Approval |
07/18/2023 |
NEXIUM NDA #021957 |
SUPPL-27 |
ESOMEPRAZOLE MAGNESIUM |
ASTRAZENECA |
Labeling |
Approval |
07/18/2023 |
PROTONIX NDA #022020 |
SUPPL-23 |
PANTOPRAZOLE SODIUM |
WYETH PHARMS |
Labeling |
Approval |
07/18/2023 |
PRILOSEC NDA #022056 |
SUPPL-26 |
OMEPRAZOLE MAGNESIUM |
COVIS |
Labeling |
Approval |
07/18/2023 |
NEXIUM NDA #022101 |
SUPPL-24 |
ESOMEPRAZOLE MAGNESIUM |
ASTRAZENECA |
Labeling |
Approval |
07/18/2023 |
DEXILANT NDA #022287 |
SUPPL-38 |
DEXLANSOPRAZOLE |
TAKEDA PHARMS USA |
Labeling |
Approval |
07/18/2023 |
VIMOVO NDA #022511 |
SUPPL-29 |
ESOMEPRAZOLE MAGNESIUM; NAPROXEN |
HORIZON |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #075347 |
SUPPL-30 |
OMEPRAZOLE |
ACTAVIS LABS FL INC |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #075410 |
SUPPL-68 |
OMEPRAZOLE |
LANNETT CO INC |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #075576 |
SUPPL-25 |
OMEPRAZOLE |
DR REDDYS LABS LTD |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #075785 |
SUPPL-14 |
OMEPRAZOLE |
IMPAX LABS |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #075876 |
SUPPL-45 |
OMEPRAZOLE |
STRIDES PHARMA |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #076048 |
SUPPL-29 |
OMEPRAZOLE |
APOTEX |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #078490 |
SUPPL-22 |
OMEPRAZOLE |
DR REDDYS LABS LTD |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #091352 |
SUPPL-23 |
OMEPRAZOLE |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #091672 |
SUPPL-24 |
OMEPRAZOLE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
07/18/2023 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #200218 |
SUPPL-10 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
ANI PHARMS |
Labeling |
Approval |
07/18/2023 |
VARENICLINE TARTRATE ANDA #201962 |
SUPPL-3 |
VARENICLINE TARTRATE |
APOTEX |
Manufacturing (CMC) |
Approval |
07/18/2023 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #202588 |
SUPPL-10 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
SANDOZ |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #203270 |
SUPPL-20 |
OMEPRAZOLE |
AUROBINDO PHARMA |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #203481 |
SUPPL-8 |
OMEPRAZOLE |
BRECKENRIDGE |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #204012 |
SUPPL-3 |
OMEPRAZOLE |
HETERO LABS LTD III |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #204661 |
SUPPL-8 |
OMEPRAZOLE |
TEVA PHARMS USA |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #205070 |
SUPPL-4 |
OMEPRAZOLE |
MYLAN |
Labeling |
Approval |
07/18/2023 |
YOSPRALA NDA #205103 |
SUPPL-9 |
ASPIRIN; OMEPRAZOLE |
GENUS LIFESCIENCES |
Labeling |
Approval |
07/18/2023 |
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) ANDA #206006 |
SUPPL-6 |
AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE |
RISING |
Labeling |
Approval |
07/18/2023 |
VILAZODONE HYDROCHLORIDE ANDA #208202 |
SUPPL-1 |
VILAZODONE HYDROCHLORIDE |
ALEMBIC |
Labeling |
Approval |
07/18/2023 |
VILAZODONE HYDROCHLORIDE ANDA #208202 |
SUPPL-2 |
VILAZODONE HYDROCHLORIDE |
ALEMBIC |
Manufacturing (CMC) |
Approval |
07/18/2023 |
VILAZODONE HYDROCHLORIDE ANDA #208202 |
SUPPL-4 |
VILAZODONE HYDROCHLORIDE |
ALEMBIC |
Labeling |
Approval |
07/18/2023 |
PANTOPRAZOLE SODIUM NDA #209463 |
SUPPL-21 |
PANTOPRAZOLE SODIUM |
HIKMA |
Labeling |
Approval |
07/18/2023 |
GOPRELTO NDA #209963 |
SUPPL-5 |
COCAINE HYDROCHLORIDE |
NODEN PHARMA |
Labeling |
Approval |
07/18/2023 |
ABSORICA LD NDA #211913 |
SUPPL-11 |
ISOTRETINOIN |
SUN PHARM |
Labeling |
Approval |
07/18/2023 |
NALOXONE HYDROCHLORIDE ANDA #211951 |
SUPPL-3 |
NALOXONE HYDROCHLORIDE |
PADAGIS ISRAEL |
Labeling |
Approval |
07/18/2023 |
OMEPRAZOLE ANDA #212977 |
SUPPL-8 |
OMEPRAZOLE |
XIROMED |
Labeling |
Approval |
07/18/2023 |
TALICIA NDA #213004 |
SUPPL-12 |
AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN |
REDHILL |
Labeling |
Approval |
07/18/2023 |
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR ALAFENAMIDE NDA #215187 |
ORIG-1 |
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR ALAFENAMIDE |
LUPIN PHARMS |
Type 4 - New Combination |
Tentative Approval |
07/18/2023 |
CHLORPROMAZINE HYDROCHLORIDE ANDA #217350 |
ORIG-1 |
CHLORPROMAZINE HYDROCHLORIDE |
ALEMBIC |
|
Approval |
07/19/2023 |
ACTIGALL NDA #019594 |
SUPPL-37 |
URSODIOL |
TEVA BRANDED PHARM |
Labeling |
Approval |
07/19/2023 |
APREMILAST ANDA #211716 |
ORIG-1 |
APREMILAST |
AUROBINDO PHARMA LTD |
|
Approval |
07/19/2023 |
FENOFIBRIC ACID ANDA #213450 |
SUPPL-1 |
CHOLINE FENOFIBRATE |
MICRO LABS |
Labeling |
Approval |
07/19/2023 |
LEUCOVORIN CALCIUM ANDA #216590 |
ORIG-1 |
LEUCOVORIN CALCIUM |
KINDOS |
|
Approval |
07/19/2023 |
GABAPENTIN ANDA #217995 |
ORIG-1 |
GABAPENTIN |
RISING |
|
Approval |
07/19/2023 |
SILIQ BLA #761032 |
SUPPL-11 |
BRODALUMAB |
VALEANT LUXEMBOURG |
|
Approval |
07/19/2023 |
CYLTEZO BLA #761058 |
SUPPL-25 |
ADALIMUMAB-ADBM |
BOEHRINGER INGELHEIM |
|
Approval |
07/20/2023 |
ELIGARD KIT NDA #021343 |
SUPPL-47 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021343 |
SUPPL-48 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021379 |
SUPPL-49 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021379 |
SUPPL-50 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ZETIA NDA #021445 |
SUPPL-42 |
EZETIMIBE |
ORGANON |
Labeling |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021488 |
SUPPL-44 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021488 |
SUPPL-45 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021731 |
SUPPL-44 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
ELIGARD KIT NDA #021731 |
SUPPL-47 |
LEUPROLIDE ACETATE |
TOLMAR |
Efficacy |
Approval |
07/20/2023 |
LEVOTHYROXINE SODIUM ANDA #076187 |
SUPPL-50 |
LEVOTHYROXINE SODIUM |
MYLAN |
Labeling |
Approval |
07/20/2023 |
FLUCONAZOLE ANDA #077253 |
SUPPL-23 |
FLUCONAZOLE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
07/20/2023 |
FLUCONAZOLE ANDA #077253 |
SUPPL-24 |
FLUCONAZOLE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
07/20/2023 |
GRANISETRON HYDROCHLORIDE ANDA #078846 |
SUPPL-3 |
GRANISETRON HYDROCHLORIDE |
DR REDDYS LABS LTD |
Labeling |
Approval |
07/20/2023 |
GRANISETRON HYDROCHLORIDE ANDA #078846 |
SUPPL-4 |
GRANISETRON HYDROCHLORIDE |
DR REDDYS LABS LTD |
Labeling |
Approval |
07/20/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #091617 |
SUPPL-35 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
ALEMBIC PHARMS LTD |
Labeling |
Approval |
07/20/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #201682 |
SUPPL-10 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
IPCA LABS LTD |
Labeling |
Approval |
07/20/2023 |
TRANEXAMIC ACID ANDA #201885 |
SUPPL-10 |
TRANEXAMIC ACID |
AM REGENT |
Labeling |
Approval |
07/20/2023 |
FLUVASTATIN SODIUM ANDA #202458 |
SUPPL-2 |
FLUVASTATIN SODIUM |
MYLAN |
Labeling |
Approval |
07/20/2023 |
FLUVASTATIN SODIUM ANDA #202458 |
SUPPL-5 |
FLUVASTATIN SODIUM |
MYLAN |
Labeling |
Approval |
07/20/2023 |
SPIRONOLACTONE ANDA #203253 |
SUPPL-18 |
SPIRONOLACTONE |
JUBILANT GENERICS |
Labeling |
Approval |
07/20/2023 |
TELMISARTAN ANDA #204415 |
SUPPL-15 |
TELMISARTAN |
AMNEAL PHARMS |
Labeling |
Approval |
07/20/2023 |
OTEZLA NDA #205437 |
SUPPL-12 |
APREMILAST |
AMGEN INC |
Efficacy |
Approval |
07/20/2023 |
AMANTADINE HYDROCHLORIDE ANDA #208278 |
SUPPL-3 |
AMANTADINE HYDROCHLORIDE |
ZYDUS PHARMS |
Labeling |
Approval |
07/20/2023 |
DEXMETHYLPHENIDATE HYDROCHLORIDE ANDA #209211 |
SUPPL-2 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
CEDIPROF INC |
Labeling |
Approval |
07/20/2023 |
AZITHROMYCIN ANDA #210001 |
SUPPL-7 |
AZITHROMYCIN |
BIONPHARMA |
Labeling |
Approval |
07/20/2023 |
AZITHROMYCIN ANDA #210001 |
SUPPL-8 |
AZITHROMYCIN |
BIONPHARMA |
Labeling |
Approval |
07/20/2023 |
GAVRETO NDA #213721 |
SUPPL-14 |
PRALSETINIB |
BLUEPRINT MEDICINES |
Labeling |
Approval |
07/20/2023 |
OBETICHOLIC ACID ANDA #214935 |
ORIG-1 |
OBETICHOLIC ACID |
OPTIMUS PHARMA PRIVATE LTD |
|
Tentative Approval |
07/20/2023 |
OMEPRAZOLE MAGNESIUM ANDA #216096 |
SUPPL-2 |
OMEPRAZOLE MAGNESIUM |
L PERRIGO CO |
Labeling |
Approval |
07/20/2023 |
ATORVASTATIN CALCIUM ANDA #216436 |
SUPPL-1 |
ATORVASTATIN CALCIUM |
BIOCON PHARMA |
Labeling |
Approval |
07/20/2023 |
VANFLYTA NDA #216993 |
ORIG-1 |
QUIZARTINIB DIHYDROCHLORIDE |
DAIICHI SANKYO INC |
Type 1 - New Molecular Entity |
Approval |
07/21/2023 |
HUMALOG BLA #020563 |
SUPPL-202 |
INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG KWIKPEN BLA #020563 |
SUPPL-202 |
INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG PEN BLA #020563 |
SUPPL-202 |
INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG TEMPO PEN BLA #020563 |
SUPPL-202 |
INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG MIX 75/25 BLA #021017 |
SUPPL-146 |
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG MIX 75/25 KWIKPEN BLA #021017 |
SUPPL-146 |
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG MIX 75/25 PEN BLA #021017 |
SUPPL-146 |
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG MIX 50/50 BLA #021018 |
SUPPL-132 |
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG MIX 50/50 KWIKPEN BLA #021018 |
SUPPL-132 |
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
HUMALOG MIX 50/50 PEN BLA #021018 |
SUPPL-132 |
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT |
LILLY |
|
Approval |
07/21/2023 |
TOBRAMYCIN AND DEXAMETHASONE ANDA #064134 |
SUPPL-25 |
DEXAMETHASONE; TOBRAMYCIN |
BAUSCH AND LOMB |
Labeling |
Approval |
07/21/2023 |
TOBRAMYCIN AND DEXAMETHASONE ANDA #064134 |
SUPPL-29 |
DEXAMETHASONE; TOBRAMYCIN |
BAUSCH AND LOMB |
Labeling |
Approval |
07/21/2023 |
DEXASPORIN ANDA #064135 |
SUPPL-42 |
DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
BAUSCH AND LOMB |
Labeling |
Approval |
07/21/2023 |
LORAZEPAM ANDA #071141 |
SUPPL-53 |
LORAZEPAM |
SANDOZ |
Labeling |
Approval |
07/21/2023 |
ANAGRELIDE HYDROCHLORIDE ANDA #076910 |
SUPPL-5 |
ANAGRELIDE HYDROCHLORIDE |
IMPAX LABS |
Labeling |
Approval |
07/21/2023 |
TORSEMIDE ANDA #076943 |
SUPPL-4 |
TORSEMIDE |
HIKMA |
Labeling |
Approval |
07/21/2023 |
ALPRAZOLAM ANDA #077741 |
SUPPL-4 |
ALPRAZOLAM |
APOTEX INC |
Labeling |
Approval |
07/21/2023 |
ALPRAZOLAM ANDA #077741 |
SUPPL-5 |
ALPRAZOLAM |
APOTEX INC |
Labeling |
Approval |
07/21/2023 |
NAPROXEN SODIUM ANDA #090545 |
SUPPL-1 |
NAPROXEN SODIUM |
MARKSANS PHARMA |
Labeling |
Approval |
07/21/2023 |
NAPROXEN SODIUM ANDA #090545 |
SUPPL-2 |
NAPROXEN SODIUM |
MARKSANS PHARMA |
Labeling |
Approval |
07/21/2023 |
NAPROXEN SODIUM ANDA #090545 |
SUPPL-4 |
NAPROXEN SODIUM |
MARKSANS PHARMA |
Labeling |
Approval |
07/21/2023 |
HUMALOG KWIKPEN BLA #205747 |
SUPPL-28 |
INSULIN LISPRO RECOMBINANT |
ELI LILLY AND CO |
|
Approval |
07/21/2023 |
LURASIDONE HYDROCHLORIDE ANDA #208052 |
SUPPL-1 |
LURASIDONE HYDROCHLORIDE |
ZYDUS PHARMS |
Labeling |
Approval |
07/21/2023 |
DEXMETHYLPHENIDATE HYDROCHLORIDE ANDA #209468 |
SUPPL-4 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
07/21/2023 |
LEVOTHYROXINE SODIUM ANDA #209713 |
SUPPL-16 |
LEVOTHYROXINE SODIUM |
LUPIN |
Labeling |
Approval |
07/21/2023 |
LEVOTHYROXINE SODIUM ANDA #209713 |
SUPPL-29 |
LEVOTHYROXINE SODIUM |
LUPIN |
Labeling |
Approval |
07/21/2023 |
TOBRAMYCIN ANDA #210871 |
SUPPL-1 |
TOBRAMYCIN |
LUOXIN AUROVITAS |
Labeling |
Approval |
07/21/2023 |
DIAZOXIDE ANDA #211050 |
SUPPL-10 |
DIAZOXIDE |
E5 PHARMA INC |
Labeling |
Approval |
07/21/2023 |
CAPECITABINE ANDA #211724 |
SUPPL-2 |
CAPECITABINE |
RELIANCE LIFE |
Labeling |
Approval |
07/21/2023 |
CAPECITABINE ANDA #211724 |
SUPPL-4 |
CAPECITABINE |
RELIANCE LIFE |
Labeling |
Approval |
07/21/2023 |
TOBRAMYCIN ANDA #212848 |
SUPPL-2 |
TOBRAMYCIN |
ALKEM LABS LTD |
Labeling |
Approval |
07/21/2023 |
YCANTH NDA #212905 |
ORIG-1 |
CANTHARIDIN |
VERRICA PHARMS |
Type 5 - New Formulation or New Manufacturer |
Approval |
07/21/2023 |
VASOPRESSIN ANDA #212944 |
SUPPL-2 |
VASOPRESSIN |
AMNEAL |
Labeling |
Approval |
07/21/2023 |
PREGABALIN ANDA #212988 |
SUPPL-1 |
PREGABALIN |
ESKAYEF |
Manufacturing (CMC) |
Approval |
07/21/2023 |
WEGOVY NDA #215256 |
SUPPL-7 |
SEMAGLUTIDE |
NOVO |
Efficacy |
Approval |
07/21/2023 |
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE ANDA #215555 |
SUPPL-2 |
CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
AMNEAL |
Labeling |
Approval |
07/21/2023 |
LACOSAMIDE ANDA #216151 |
SUPPL-2 |
LACOSAMIDE |
NOVITIUM PHARMA |
Labeling |
Approval |
07/21/2023 |
LACOSAMIDE ANDA #216151 |
SUPPL-4 |
LACOSAMIDE |
NOVITIUM PHARMA |
Labeling |
Approval |
07/23/2023 |
ROPIVACAINE HYDROCHLORIDE ANDA #090318 |
SUPPL-5 |
ROPIVACAINE HYDROCHLORIDE |
RISING |
Labeling |
Approval |
07/23/2023 |
ROPIVACAINE HYDROCHLORIDE ANDA #090318 |
SUPPL-7 |
ROPIVACAINE HYDROCHLORIDE |
RISING |
Labeling |
Approval |
07/24/2023 |
PLAQUENIL NDA #009768 |
SUPPL-60 |
HYDROXYCHLOROQUINE SULFATE |
CONCORDIA |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #040516 |
SUPPL-16 |
CHLOROQUINE PHOSPHATE |
IMPAX LABS |
Labeling |
Approval |
07/24/2023 |
CLONAZEPAM ANDA #077147 |
SUPPL-11 |
CLONAZEPAM |
ACCORD HLTHCARE |
Labeling |
Approval |
07/24/2023 |
CLONAZEPAM ANDA #077147 |
SUPPL-13 |
CLONAZEPAM |
ACCORD HLTHCARE |
Labeling |
Approval |
07/24/2023 |
CLONAZEPAM ANDA #077147 |
SUPPL-14 |
CLONAZEPAM |
ACCORD HLTHCARE |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #080880 |
SUPPL-68 |
CHLOROQUINE PHOSPHATE |
IMPAX LABS |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #083082 |
SUPPL-59 |
CHLOROQUINE PHOSPHATE |
HIKMA PHARMS |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #090249 |
SUPPL-8 |
CHLOROQUINE PHOSPHATE |
IPCA LABS LTD |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #090610 |
SUPPL-10 |
CHLOROQUINE PHOSPHATE |
IPCA LABS LTD |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #090612 |
SUPPL-6 |
CHLOROQUINE PHOSPHATE |
NATCO PHARMA LTD |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #091621 |
SUPPL-6 |
CHLOROQUINE PHOSPHATE |
NATCO PHARMA LTD |
Labeling |
Approval |
07/24/2023 |
COSENTYX BLA #125504 |
SUPPL-54 |
SECUKINUMAB |
NOVARTIS PHARMS CORP |
|
Approval |
07/24/2023 |
COSENTYX BLA #125504 |
SUPPL-55 |
SECUKINUMAB |
NOVARTIS PHARMS CORP |
|
Approval |
07/24/2023 |
COSENTYX BLA #125504 |
SUPPL-67 |
SECUKINUMAB |
NOVARTIS PHARMS CORP |
|
Approval |
07/24/2023 |
DEXMETHYLPHENIDATE HYDROCHLORIDE ANDA #201231 |
SUPPL-11 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
07/24/2023 |
DEXMETHYLPHENIDATE HYDROCHLORIDE ANDA #201231 |
SUPPL-13 |
DEXMETHYLPHENIDATE HYDROCHLORIDE |
SUN PHARM INDUSTRIES |
Labeling |
Approval |
07/24/2023 |
PLERIXAFOR ANDA #205182 |
ORIG-1 |
PLERIXAFOR |
DR REDDYS |
|
Approval |
07/24/2023 |
PLERIXAFOR ANDA #205197 |
ORIG-1 |
PLERIXAFOR |
TEVA PHARMS USA INC |
|
Approval |
07/24/2023 |
PLERIXAFOR ANDA #211901 |
ORIG-1 |
PLERIXAFOR |
MSN |
|
Approval |
07/24/2023 |
ICATIBANT ACETATE ANDA #212446 |
SUPPL-3 |
ICATIBANT ACETATE |
CIPLA |
Labeling |
Approval |
07/24/2023 |
BUMETANIDE ANDA #213458 |
ORIG-1 |
BUMETANIDE |
TARO |
|
Approval |
07/24/2023 |
PLERIXAFOR ANDA #213672 |
ORIG-1 |
PLERIXAFOR |
EUGIA PHARMA |
|
Approval |
07/24/2023 |
TIROFIBAN HYDROCHLORIDE ANDA #213947 |
ORIG-2 |
TIROFIBAN HYDROCHLORIDE |
NEXUS |
|
Approval |
07/24/2023 |
SOVUNA NDA #214581 |
SUPPL-7 |
HYDROXYCHLOROQUINE SULFATE |
NOVITIUM PHARMA |
Labeling |
Approval |
07/24/2023 |
CHLOROQUINE PHOSPHATE ANDA #214756 |
SUPPL-4 |
CHLOROQUINE PHOSPHATE |
SUVEN PHARMS |
Labeling |
Approval |
07/24/2023 |
PLERIXAFOR ANDA #215334 |
ORIG-1 |
PLERIXAFOR |
AMNEAL |
|
Approval |
07/24/2023 |
PLERIXAFOR ANDA #215698 |
ORIG-1 |
PLERIXAFOR |
KINDOS |
|
Approval |
07/24/2023 |
XDEMVY NDA #217603 |
ORIG-1 |
LOTILANER |
TARSUS |
Type 1 - New Molecular Entity |
Approval |
07/25/2023 |
METOPIRONE NDA #012911 |
SUPPL-39 |
METYRAPONE |
HRA PHARMA |
Labeling |
Approval |
07/25/2023 |
TAMOXIFEN CITRATE ANDA #074732 |
SUPPL-15 |
TAMOXIFEN CITRATE |
MYLAN |
Manufacturing (CMC) |
Approval |
07/25/2023 |
TAMSULOSIN HYDROCHLORIDE ANDA #090377 |
SUPPL-11 |
TAMSULOSIN HYDROCHLORIDE |
IMPAX LABS |
Labeling |
Approval |
07/25/2023 |
ATORVASTATIN CALCIUM ANDA #090548 |
SUPPL-25 |
ATORVASTATIN CALCIUM |
APOTEX INC |
Labeling |
Approval |
07/25/2023 |
ATORVASTATIN CALCIUM ANDA #090548 |
SUPPL-26 |
ATORVASTATIN CALCIUM |
APOTEX INC |
Labeling |
Approval |
07/25/2023 |
ATORVASTATIN CALCIUM ANDA #090548 |
SUPPL-27 |
ATORVASTATIN CALCIUM |
APOTEX INC |
Labeling |
Approval |
07/25/2023 |
DOXYCYCLINE HYCLATE ANDA #207289 |
SUPPL-7 |
DOXYCYCLINE HYCLATE |
AMNEAL PHARMS |
Labeling |
Approval |
07/25/2023 |
DOXYCYCLINE HYCLATE ANDA #207774 |
SUPPL-4 |
DOXYCYCLINE HYCLATE |
ZYDUS LIFESCIENCES |
Labeling |
Approval |
07/25/2023 |
RANOLAZINE ANDA #213085 |
ORIG-1 |
RANOLAZINE |
PIRAMAL HLTHCARE UK |
|
Approval |
07/25/2023 |
FOSAPREPITANT DIMEGLUMINE ANDA #213106 |
SUPPL-3 |
FOSAPREPITANT DIMEGLUMINE |
QILU PHARM HAINAN |
Labeling |
Approval |
07/25/2023 |
FOSAPREPITANT DIMEGLUMINE ANDA #213106 |
SUPPL-5 |
FOSAPREPITANT DIMEGLUMINE |
QILU PHARM HAINAN |
Labeling |
Approval |
07/25/2023 |
CARBOPROST TROMETHAMINE ANDA #216897 |
ORIG-1 |
CARBOPROST TROMETHAMINE |
STERISCIENCE |
|
Approval |
07/25/2023 |
VARENICLINE TARTRATE ANDA #217151 |
ORIG-1 |
VARENICLINE TARTRATE |
LEADING PHARMA |
|
Approval |
07/26/2023 |
HIBICLENS NDA #017768 |
SUPPL-59 |
CHLORHEXIDINE GLUCONATE |
MOLNLYCKE HLTH |
Labeling |
Approval |
07/26/2023 |
COREG NDA #020297 |
SUPPL-39 |
CARVEDILOL |
WAYLIS THERAP |
Labeling |
Approval |
07/26/2023 |
COREG CR NDA #022012 |
SUPPL-24 |
CARVEDILOL PHOSPHATE |
WAYLIS THERAP |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-54 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-55 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-56 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-57 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-58 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-59 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-60 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-61 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-72 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-74 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
DOXYCYCLINE HYCLATE ANDA #062396 |
SUPPL-77 |
DOXYCYCLINE HYCLATE |
HIKMA INTL PHARMS |
Labeling |
Approval |
07/26/2023 |
SERTRALINE HYDROCHLORIDE ANDA #077206 |
SUPPL-38 |
SERTRALINE HYDROCHLORIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
07/26/2023 |
SERTRALINE HYDROCHLORIDE ANDA #077206 |
SUPPL-39 |
SERTRALINE HYDROCHLORIDE |
AUROBINDO PHARMA |
Labeling |
Approval |
07/26/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #090865 |
SUPPL-21 |
PRAMIPEXOLE DIHYDROCHLORIDE |
TORRENT PHARMS |
Labeling |
Approval |
07/26/2023 |
PRAMIPEXOLE DIHYDROCHLORIDE ANDA #090865 |
SUPPL-22 |
PRAMIPEXOLE DIHYDROCHLORIDE |
TORRENT PHARMS |
Labeling |
Approval |
07/26/2023 |
FEBUXOSTAT ANDA #205414 |
SUPPL-1 |
FEBUXOSTAT |
HIKMA |
Labeling |
Approval |
07/26/2023 |
FEBUXOSTAT ANDA #205421 |
SUPPL-13 |
FEBUXOSTAT |
ALEMBIC |
Labeling |
Approval |
07/26/2023 |
PLERIXAFOR ANDA #208980 |
ORIG-1 |
PLERIXAFOR |
ZYDUS PHARMS |
|
Approval |
07/26/2023 |
COLESEVELAM HYDROCHLORIDE ANDA #209946 |
SUPPL-2 |
COLESEVELAM HYDROCHLORIDE |
ZHEJIANG JINGXIN |
Labeling |
Approval |
07/26/2023 |
APREMILAST ANDA #211878 |
ORIG-1 |
APREMILAST |
ANNORA |
|
Approval |
07/26/2023 |
BRIVARACETAM ANDA #214918 |
SUPPL-1 |
BRIVARACETAM |
LUPIN LTD |
Labeling |
Approval |
07/26/2023 |
MEROPENEM NDA #215212 |
ORIG-1 |
MEROPENEM |
HQ SPCLT PHARMA |
Type 5 - New Formulation or New Manufacturer |
Approval |
07/26/2023 |
ELZONRIS BLA #761116 |
SUPPL-9 |
TAGRAXOFUSP-ERZS |
STEMLINE THERAPEUTICS INC |
|
Approval |
07/26/2023 |
TIVDAK BLA #761208 |
SUPPL-5 |
TISOTUMAB VEDOTIN-TFTV |
SEAGEN |
|
Approval |
07/27/2023 |
SOMAVERT BLA #021106 |
SUPPL-74 |
PEGVISOMANT |
PHARMACIA |
|
Approval |
07/27/2023 |
CRESTOR NDA #021366 |
SUPPL-45 |
ROSUVASTATIN CALCIUM |
IPR |
Labeling |
Approval |
07/27/2023 |
MIRALAX NDA #022015 |
SUPPL-47 |
POLYETHYLENE GLYCOL 3350 |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
07/27/2023 |
NESINA NDA #022271 |
SUPPL-15 |
ALOGLIPTIN BENZOATE |
TAKEDA PHARMS USA |
Efficacy |
Approval |
07/27/2023 |
KEPIVANCE BLA #125103 |
SUPPL-186 |
PALIFERMIN |
BIOVITRUM AB |
|
Approval |
07/27/2023 |
ULSPIRA ANDA #203144 |
ORIG-1 |
NITRIC OXIDE |
AIRGAS THERAP |
|
Approval |
07/27/2023 |
KAZANO NDA #203414 |
SUPPL-16 |
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
TAKEDA PHARMS USA |
Efficacy |
Approval |
07/27/2023 |
GALLIUM GA 68 EDOTREOTIDE NDA #210828 |
SUPPL-3 |
GALLIUM GA-68 EDOTREOTIDE |
UIHC PET IMAGING |
Labeling |
Approval |
07/27/2023 |
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE NDA #215700 |
SUPPL-2 |
NOREPINEPHRINE BITARTRATE |
INFORLIFE |
Labeling |
Approval |
07/27/2023 |
AZITHROMYCIN ANDA #217036 |
ORIG-1 |
AZITHROMYCIN |
HAINAN POLY |
|
Approval |
07/27/2023 |
TOBRAMYCIN ANDA #217344 |
ORIG-1 |
TOBRAMYCIN |
MICRO LABS |
|
Approval |
07/28/2023 |
LOVENOX NDA #020164 |
SUPPL-101 |
ENOXAPARIN SODIUM |
SANOFI AVENTIS US |
Labeling |
Approval |
07/28/2023 |
LOVENOX (PRESERVATIVE FREE) NDA #020164 |
SUPPL-101 |
ENOXAPARIN SODIUM |
SANOFI AVENTIS US |
Labeling |
Approval |
07/28/2023 |
DIVALPROEX SODIUM ANDA #078239 |
SUPPL-26 |
DIVALPROEX SODIUM |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
07/28/2023 |
DIVALPROEX SODIUM ANDA #078239 |
SUPPL-27 |
DIVALPROEX SODIUM |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
07/28/2023 |
DIVALPROEX SODIUM ANDA #078239 |
SUPPL-29 |
DIVALPROEX SODIUM |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
07/28/2023 |
DIVALPROEX SODIUM ANDA #078239 |
SUPPL-32 |
DIVALPROEX SODIUM |
ZYDUS PHARMS USA INC |
Labeling |
Approval |
07/28/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #090528 |
SUPPL-27 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TORRENT PHARMS |
Labeling |
Approval |
07/28/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #090528 |
SUPPL-31 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TORRENT PHARMS |
Labeling |
Approval |
07/28/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #090528 |
SUPPL-33 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
TORRENT PHARMS |
Labeling |
Approval |
07/28/2023 |
BETASERON BLA #103471 |
SUPPL-5202 |
INTERFERON BETA-1B |
BAYER HEALTHCARE PHARMS |
|
Approval |
07/28/2023 |
AVONEX BLA #103628 |
SUPPL-5269 |
INTERFERON BETA-1A |
BIOGEN |
|
Approval |
07/28/2023 |
REBIF BLA #103780 |
SUPPL-5214 |
INTERFERON BETA-1A |
SERONO INC |
|
Approval |
07/28/2023 |
PLEGRIDY BLA #125499 |
SUPPL-28 |
PEGINTERFERON BETA-1A |
BIOGEN IDEC INC |
|
Approval |
07/28/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #202289 |
SUPPL-19 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/28/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #202289 |
SUPPL-36 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/28/2023 |
CALCITRIOL ANDA #203973 |
ORIG-1 |
CALCITRIOL |
PATRIN |
|
Approval |
07/28/2023 |
BUPROPION HYDROCHLORIDE ANDA #205794 |
SUPPL-28 |
BUPROPION HYDROCHLORIDE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/28/2023 |
CINACALCET HYDROCHLORIDE ANDA #206125 |
SUPPL-8 |
CINACALCET HYDROCHLORIDE |
AUROBINDO PHARMA LTD |
Labeling |
Approval |
07/28/2023 |
DICLOFENAC SODIUM ANDA #206298 |
SUPPL-1 |
DICLOFENAC SODIUM |
TARO |
Labeling |
Approval |
07/28/2023 |
DICLOFENAC SODIUM ANDA #206298 |
SUPPL-7 |
DICLOFENAC SODIUM |
TARO |
Labeling |
Approval |
07/28/2023 |
DICLOFENAC SODIUM ANDA #206298 |
SUPPL-8 |
DICLOFENAC SODIUM |
TARO |
Labeling |
Approval |
07/28/2023 |
CLOPIDOGREL BISULFATE ANDA #206376 |
SUPPL-3 |
CLOPIDOGREL BISULFATE |
PRINSTON INC |
Labeling |
Approval |
07/28/2023 |
CLOPIDOGREL BISULFATE ANDA #206376 |
SUPPL-4 |
CLOPIDOGREL BISULFATE |
PRINSTON INC |
Labeling |
Approval |
07/28/2023 |
LAMOTRIGINE ANDA #206382 |
SUPPL-12 |
LAMOTRIGINE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/28/2023 |
LAMOTRIGINE ANDA #206382 |
SUPPL-13 |
LAMOTRIGINE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/28/2023 |
LAMOTRIGINE ANDA #206382 |
SUPPL-14 |
LAMOTRIGINE |
SCIEGEN PHARMS INC |
Labeling |
Approval |
07/28/2023 |
NOXIVENT ANDA #207141 |
SUPPL-4 |
NITRIC OXIDE |
LINDE GAS EQUIP |
Labeling |
Approval |
07/28/2023 |
SIROLIMUS ANDA #211212 |
SUPPL-1 |
SIROLIMUS |
AMNEAL |
Labeling |
Approval |
07/28/2023 |
SIROLIMUS ANDA #211212 |
SUPPL-4 |
SIROLIMUS |
AMNEAL |
Labeling |
Approval |
07/28/2023 |
SUCCINYLCHOLINE CHLORIDE ANDA #211432 |
SUPPL-11 |
SUCCINYLCHOLINE CHLORIDE |
AMNEAL |
Labeling |
Approval |
07/28/2023 |
LORATADINE ANDA #211718 |
ORIG-1 |
LORATADINE |
HETERO LABS LTD V |
|
Approval |
07/28/2023 |
BRINZOLAMIDE ANDA #211914 |
ORIG-1 |
BRINZOLAMIDE |
PADAGIS US |
|
Approval |
07/28/2023 |
TRIFERIC AVNU NDA #212860 |
SUPPL-1 |
FERRIC PYROPHOSPHATE CITRATE |
ROCKWELL MEDICAL INC |
Labeling |
Approval |
07/28/2023 |
PHYTONADIONE ANDA #213329 |
ORIG-1 |
PHYTONADIONE |
SCIEGEN PHARMS INC |
|
Approval |
07/28/2023 |
ZEPZELCA NDA #213702 |
SUPPL-8 |
LURBINECTEDIN |
JAZZ |
Labeling |
Approval |
07/28/2023 |
DEXAMETHASONE SODIUM PHOSPHATE ANDA #214891 |
ORIG-1 |
DEXAMETHASONE SODIUM PHOSPHATE |
GENEYORK PHARMS |
|
Approval |
07/28/2023 |
MOUNJARO NDA #215866 |
SUPPL-2 |
TIRZEPATIDE |
ELI LILLY AND CO |
Labeling |
Approval |
07/28/2023 |
MOUNJARO NDA #215866 |
SUPPL-6 |
TIRZEPATIDE |
ELI LILLY AND CO |
Labeling |
Approval |
07/28/2023 |
MOUNJARO (AUTOINJECTOR) NDA #215866 |
SUPPL-2 |
TIRZEPATIDE |
ELI LILLY AND CO |
Labeling |
Approval |
07/28/2023 |
MOUNJARO (AUTOINJECTOR) NDA #215866 |
SUPPL-6 |
TIRZEPATIDE |
ELI LILLY AND CO |
Labeling |
Approval |
07/28/2023 |
RIVIVE NDA #217722 |
ORIG-1 |
NALOXONE HYDROCHLORIDE |
HARM REDUCTION THERP |
Type 5 - New Formulation or New Manufacturer |
Approval |
07/31/2023 |
SIMVASTATIN ANDA #076052 |
SUPPL-44 |
SIMVASTATIN |
IVAX SUB TEVA PHARMS |
Labeling |
Approval |
07/31/2023 |
SIMVASTATIN ANDA #076052 |
SUPPL-48 |
SIMVASTATIN |
IVAX SUB TEVA PHARMS |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077296 |
SUPPL-9 |
DIVALPROEX SODIUM |
CHARTWELL RX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077296 |
SUPPL-10 |
DIVALPROEX SODIUM |
CHARTWELL RX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077296 |
SUPPL-11 |
DIVALPROEX SODIUM |
CHARTWELL RX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077296 |
SUPPL-12 |
DIVALPROEX SODIUM |
CHARTWELL RX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077615 |
SUPPL-18 |
DIVALPROEX SODIUM |
APOTEX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077615 |
SUPPL-19 |
DIVALPROEX SODIUM |
APOTEX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077615 |
SUPPL-20 |
DIVALPROEX SODIUM |
APOTEX |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #077615 |
SUPPL-21 |
DIVALPROEX SODIUM |
APOTEX |
Labeling |
Approval |
07/31/2023 |
SIMVASTATIN ANDA #077691 |
SUPPL-47 |
SIMVASTATIN |
AUROBINDO PHARMA |
Labeling |
Approval |
07/31/2023 |
SIMVASTATIN ANDA #078155 |
SUPPL-39 |
SIMVASTATIN |
ACCORD HLTHCARE |
Labeling |
Approval |
07/31/2023 |
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE ANDA #078245 |
SUPPL-40 |
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
LUPIN LTD |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #078790 |
SUPPL-25 |
DIVALPROEX SODIUM |
LUPIN |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #078790 |
SUPPL-26 |
DIVALPROEX SODIUM |
LUPIN |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #078790 |
SUPPL-27 |
DIVALPROEX SODIUM |
LUPIN |
Labeling |
Approval |
07/31/2023 |
DIVALPROEX SODIUM ANDA #078790 |
SUPPL-28 |
DIVALPROEX SODIUM |
LUPIN |
Labeling |
Approval |
07/31/2023 |
SIMVASTATIN ANDA #200895 |
SUPPL-13 |
SIMVASTATIN |
HETERO LABS LTD III |
Labeling |
Approval |
07/31/2023 |
LEVONORGESTREL ANDA #202739 |
SUPPL-4 |
LEVONORGESTREL |
MYLAN LABS LTD |
Labeling |
Approval |
07/31/2023 |
LEVONORGESTREL ANDA #202739 |
SUPPL-5 |
LEVONORGESTREL |
MYLAN LABS LTD |
Labeling |
Approval |
07/31/2023 |
TURQOZ ANDA #202980 |
ORIG-1 |
ETHINYL ESTRADIOL; NORGESTREL |
LUPIN LTD |
|
Approval |
07/31/2023 |
ASHLYNA ANDA #203163 |
SUPPL-3 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
GLENMARK PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
ASHLYNA ANDA #203163 |
SUPPL-5 |
ETHINYL ESTRADIOL; LEVONORGESTREL |
GLENMARK PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
MONTELUKAST SODIUM ANDA #203582 |
SUPPL-4 |
MONTELUKAST SODIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
MONTELUKAST SODIUM ANDA #203582 |
SUPPL-10 |
MONTELUKAST SODIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
MONTELUKAST SODIUM ANDA #203582 |
SUPPL-13 |
MONTELUKAST SODIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
MONTELUKAST SODIUM ANDA #203582 |
SUPPL-16 |
MONTELUKAST SODIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
MONTELUKAST SODIUM ANDA #203582 |
SUPPL-20 |
MONTELUKAST SODIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
MONTELUKAST SODIUM ANDA #203582 |
SUPPL-22 |
MONTELUKAST SODIUM |
MACLEODS PHARMS LTD |
Labeling |
Approval |
07/31/2023 |
SAXAGLIPTIN ANDA #205941 |
ORIG-1 |
SAXAGLIPTIN HYDROCHLORIDE |
AMNEAL |
|
Approval |
07/31/2023 |
SAXAGLIPTIN ANDA #205972 |
ORIG-1 |
SAXAGLIPTIN HYDROCHLORIDE |
AUROBINDO PHARMA |
|
Approval |
07/31/2023 |
SAXAGLIPTIN ANDA #205980 |
ORIG-1 |
SAXAGLIPTIN HYDROCHLORIDE |
MYLAN |
|
Approval |
07/31/2023 |
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE ANDA #205981 |
ORIG-1 |
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE |
MYLAN |
|
Approval |
07/31/2023 |
SAXAGLIPTIN ANDA #205994 |
ORIG-1 |
SAXAGLIPTIN HYDROCHLORIDE |
GLENMARK PHARMS LTD |
|
Approval |
07/31/2023 |
SAXAGLIPTIN ANDA #206078 |
ORIG-1 |
SAXAGLIPTIN HYDROCHLORIDE |
SUN PHARM |
|
Approval |
07/31/2023 |
SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE ANDA #206081 |
ORIG-1 |
METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE |
SUN PHARM |
|
Approval |
07/31/2023 |
FLUOCINOLONE ACETONIDE ANDA #207345 |
ORIG-1 |
FLUOCINOLONE ACETONIDE |
NOVEL LABS INC |
|
Approval |
07/31/2023 |
ARTESUNATE NDA #213036 |
SUPPL-4 |
ARTESUNATE |
AMIVAS |
Labeling |
Approval |
07/31/2023 |
ESLICARBAZEPINE ACETATE ANDA #216481 |
ORIG-1 |
ESLICARBAZEPINE ACETATE |
AUROBINDO PHARMA LTD |
|
Tentative Approval |
07/31/2023 |
ARGATROBAN ANDA #217848 |
ORIG-1 |
ARGATROBAN |
GLAND PHARMA LTD |
|
Approval |
07/31/2023 |
JEMPERLI BLA #761174 |
SUPPL-6 |
DOSTARLIMAB-GXLY |
GLAXOSMITHKLINE |
|
Approval |